Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingrid Kockum

Showing results (21-30 of 206) with videos related to

Pageof 21
Sort By:
Annals of the New York Academy of Sciences|January 6, 2009
Risk conferred by HLA-DR and DQ for type 1 diabetes in 0-35-year age group in SwedenCarani B Sanjeevi, Saikiran K Sedimbi, Mona Landin-Olsson, et al.
Journal of Personalized Medicine|September 23, 2022
A Scoping Review on Body Fluid Biomarkers for Prognosis and Disease Activity in Patients with Multiple SclerosisNadia Barizzone, Maurizio Leone, Alessandro Pizzino, et al.
The Journal of Urology|September 17, 2004
Genome-wide linkage analysis for hypospadias susceptibility genesLouise Frisén, Cilla Söderhäll, Margareta Tapper-Persson, et al.
Sleep|July 8, 2024
Adolescent sleep patterns, genetic predisposition, and risk of multiple sclerosisEva Johansson, Tomas Olsson, Pernilla Strid, et al.
Annals of Clinical and Translational Neurology|January 2, 2020
Confounding effect of blood volume and body mass index on blood neurofilament light chain levelsAli Manouchehrinia, Fredrik Piehl, Jan Hillert, et al.
Molecular & Cellular Proteomics : MCP|October 1, 2021
Assessing the Preanalytical Variability of Plasma and Cerebrospinal Fluid Processing and Its Effects on Inflammation-Related Protein BiomarkersJesse Huang, Mohsen Khademi, Örjan Lindhe, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2017
Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimodFredrik Piehl, Ingrid Kockum, Mohsen Khademi, et al.
The Journal of Clinical Endocrinology and Metabolism|September 22, 2005
The valine allele of the V89L polymorphism in the 5-alpha-reductase gene confers a reduced risk for hypospadiasHanh T T Thai, Mina Kalbasi, Kristina Lagerstedt, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 2, 2019
The influence of human leukocyte antigen-DRB1*15:01 and its interaction with smoking in MS development is dependent on DQA1*01:01 statusAnna Karin Hedström, Ola Hössjer, Jan Hillert, et al.
Frontiers in Immunology|March 21, 2022
Smoking Attributable Risk in Multiple SclerosisAli Manouchehrinia, Jesse Huang, Jan Hillert, et al.
Pageof 21

Showing results (21-30 of 206) with videos related to

Sort By:
Pageof 21
Annals of the New York Academy of Sciences|January 6, 2009
Risk conferred by HLA-DR and DQ for type 1 diabetes in 0-35-year age group in SwedenCarani B Sanjeevi, Saikiran K Sedimbi, Mona Landin-Olsson, et al.
Journal of Personalized Medicine|September 23, 2022
A Scoping Review on Body Fluid Biomarkers for Prognosis and Disease Activity in Patients with Multiple SclerosisNadia Barizzone, Maurizio Leone, Alessandro Pizzino, et al.
The Journal of Urology|September 17, 2004
Genome-wide linkage analysis for hypospadias susceptibility genesLouise Frisén, Cilla Söderhäll, Margareta Tapper-Persson, et al.
Sleep|July 8, 2024
Adolescent sleep patterns, genetic predisposition, and risk of multiple sclerosisEva Johansson, Tomas Olsson, Pernilla Strid, et al.
Annals of Clinical and Translational Neurology|January 2, 2020
Confounding effect of blood volume and body mass index on blood neurofilament light chain levelsAli Manouchehrinia, Fredrik Piehl, Jan Hillert, et al.
Molecular & Cellular Proteomics : MCP|October 1, 2021
Assessing the Preanalytical Variability of Plasma and Cerebrospinal Fluid Processing and Its Effects on Inflammation-Related Protein BiomarkersJesse Huang, Mohsen Khademi, Örjan Lindhe, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2017
Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimodFredrik Piehl, Ingrid Kockum, Mohsen Khademi, et al.
The Journal of Clinical Endocrinology and Metabolism|September 22, 2005
The valine allele of the V89L polymorphism in the 5-alpha-reductase gene confers a reduced risk for hypospadiasHanh T T Thai, Mina Kalbasi, Kristina Lagerstedt, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 2, 2019
The influence of human leukocyte antigen-DRB1*15:01 and its interaction with smoking in MS development is dependent on DQA1*01:01 statusAnna Karin Hedström, Ola Hössjer, Jan Hillert, et al.
Frontiers in Immunology|March 21, 2022
Smoking Attributable Risk in Multiple SclerosisAli Manouchehrinia, Jesse Huang, Jan Hillert, et al.
Pageof 21